BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15327403)

  • 1. Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.
    Ma G; Allen TJ; Cooper ME; Cao Z
    Kidney Int; 2004 Sep; 66(3):1090-8. PubMed ID: 15327403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
    Baylis C; Qiu C; Engels K
    Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats.
    Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A
    Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.
    Davis BJ; Cao Z; de Gasparo M; Kawachi H; Cooper ME; Allen TJ
    J Hypertens; 2003 Jan; 21(1):209-16. PubMed ID: 12544453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model.
    Griffin KA; Picken M; Bakris GL; Bidani AK
    Hypertension; 2001 May; 37(5):1268-72. PubMed ID: 11358939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats.
    Karam H; Clozel JP; Bruneval P; Gonzalez MF; Ménard J
    Hypertension; 1999 Oct; 34(4 Pt 1):673-8. PubMed ID: 10523345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
    Greven J
    Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early blood pressure normalization independent of the class of antihypertensive agent prevents augmented renal fibronectin and albuminuria in experimental diabetic nephropathy.
    Lehfeld LS; Silveira LA; Ghini B; Lopes de Faria JB
    Kidney Blood Press Res; 2004; 27(2):114-20. PubMed ID: 15051931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and rationale of Japanese evaluation between Formula of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study (J-FLAG) : evaluation of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria.
    Ando K; Haneda M; Ito S; Kashihara N; Node K; Nangaku M; Shimosawa T; Kishimoto J; Fujita T
    Cardiovasc Drugs Ther; 2011 Aug; 25(4):341-7. PubMed ID: 21637969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes.
    Chen J; Gu Y; Lin F; Yang H; Zhu W; Ma J; Lin S
    Chin Med J (Engl); 2002 Jul; 115(7):972-8. PubMed ID: 12150723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the two new calcium channel blockers mebudipine and dibudipine in comparison to amlodipine on vascular flow of isolated kidney of diabetic rat.
    Sepehr-Ara L; Sepehr-Ara M; Mahmoudian M
    Acta Physiol Hung; 2010 Sep; 97(3):281-9. PubMed ID: 20843766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium channel blockers on "dynamic" and "steady-state step" renal autoregulation.
    Griffin KA; Hacioglu R; Abu-Amarah I; Loutzenhiser R; Williamson GA; Bidani AK
    Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1136-43. PubMed ID: 14996672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
    Nakamura Y; Ono H; Frohlich ED
    Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy.
    de Alencar Franco Costa D; Todiras M; Campos LA; Cipolla-Neto J; Bader M; Baltatu OC
    Acta Physiol (Oxf); 2015 Mar; 213(3):740-6. PubMed ID: 25529203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
    Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
    J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
    Min JY; Sandmann S; Meissner A; Unger T; Simon R
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and rationale of the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.
    Matsuoka H; Ando K; Ueshima K; Babazono T; Kario K; Tanaka S; Nakao K; Fujita T;
    Clin Exp Hypertens; 2011; 33(7):455-62. PubMed ID: 21649534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
    Sandmann S; Claas R; Cleutjens JP; Daemen MJ; Unger T
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):64-77. PubMed ID: 11152376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
    Lapointe N; Chen H; Qi S; Xu D; Daloze P; Dumont L
    Eur Surg Res; 1999; 31(3):259-66. PubMed ID: 10352354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.